Career QnA

Read about the career choices our mentors have made to become established biotech professionals. Each month, a new mentor will share their career journeys and advice for those wishing to follow in their footsteps.

Dr. Catherine Campbell

Ashraf Amlani - Tuesday, November 30, 2010

Dr. Catherine Campbell is a corporate development associate at Allon Therapeutics Inc, a clinical-stage biotech company focused on developing the first drugs that impact the progression of neurodegenerative diseases. Allon’s lead drug davunetide, is proceeding in Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP). Catherine obtained her B. Sc in Biochmeistry from Concordia University in Montreal, QC. Upon completion of her Ph.D. in Neuroscience from the University of British Columbia, BC, Catherine entered the WestLink Technology Commercialization Internship Program to explore non-academic options to stay connected with her industry. Through WestLink, Catherine completed placements at SFU's Technology Transfer office, Allon Therapeutics and NDI Capital. Away from her desk, Catherine enjoys exploring the many hiking trails in Vancouver.

SBN: Describe a typical day and what you enjoy the most about it.

I work on so many different projects, it’s hard to describe a single day… but most of the time, I will answer/write e-mails, read scientific papers, do some online research for information, attend meetings and plan projects. I enjoy the diversity of work, from participating in the scientific discussions, to researching competitive information. I'm also involved in planning the drug development and corresponding with the Food and Drug Administration (FDA).

SBN: Describe some of the biggest challenges that you face at Allon Therapeutics.

CC: Dealing with unexpected problems is definitely one of the greatest challenges. There are always issues that arise in drug development, and finding solutions around these problems requires a lot of thinking and creativity.

SBN: What attracted you to this profession & what is your inspiration?

CC: I love the idea of helping find treatments for incurable diseases.

SBN: What challenges did you encounter while establishing your career and how did you overcome them?Catherine Campbell

CC: Having a background in the purely academic research area made for a difficult transition into industry. Thankfully, I had some business experience through various hobbies and extra-curricular activities. Also, networking played a crucial part in my transition from academia into industry.

SBN: Any advice you would like to share with those wishing to continue in your footsteps?

CC: Perseverance and a lot of networking can open doors you never expected.

SBN: What is your favourite quote?

CC: “Every accomplishment starts with the decision to try.” -Anonymous

Student Biotechnology Network on LinkedIn

Post has no comments.
Post a Comment

Captcha Image

[ SBN would not be possible without its generous sponsors ]